Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Osmotica Pharmaceuticals plc | osmt-20191231ex322b98716.htm |
| EX-31.2 - EX-31.2 - Osmotica Pharmaceuticals plc | osmt-20191231ex312cfbe17.htm |
| EX-31.1 - EX-31.1 - Osmotica Pharmaceuticals plc | osmt-20191231ex31145d621.htm |
| EX-23.2 - EX-23.2 - Osmotica Pharmaceuticals plc | osmt-20191231ex2320e0427.htm |
| EX-23.1 - EX-23.1 - Osmotica Pharmaceuticals plc | osmt-20191231ex231a00610.htm |
| EX-21.1 - EX-21.1 - Osmotica Pharmaceuticals plc | osmt-20191231ex2110163ba.htm |
| EX-10.37 - EX-10.37 - Osmotica Pharmaceuticals plc | osmt-20191231ex10379f85d.htm |
| EX-10.36 - EX-10.36 - Osmotica Pharmaceuticals plc | osmt-20191231ex103680d9c.htm |
| EX-10.35 - EX-10.35 - Osmotica Pharmaceuticals plc | osmt-20191231ex10351998f.htm |
| EX-4.3 - EX-4.3 - Osmotica Pharmaceuticals plc | osmt-20191231ex439b86345.htm |
| 10-K - 10-K - Osmotica Pharmaceuticals plc | osmt-20191231x10k.htm |
Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual report of Osmotica Pharmaceuticals plc (the “Company”) on Form 10-K for the year ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Brian Markison, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: March 19, 2020 |
|
|
|
|
|
|
|
|
|
/s/ Brian Markison |
|
|
Brian Markison |
|
|
Chief Executive Officer (Principal Executive Officer) |